Author:
McClorey Graham,Wood Matthew J
Funder
Association Francaise contre les Myopathies
Subject
Drug Discovery,Pharmacology
Reference36 articles.
1. Preclinical and clinical development of siRNA-based therapeutics;Ozcan;Adv Drug Deliv Rev,2015
2. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses;Sekijima;Curr Pharm Des,2008
3. Safety and efficacy of RNAi therapy for transthyretin amyloidosis;Coelho;N Engl J Med,2013
4. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial;Fitzgerald;Lancet,2014
5. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk;Sniderman;Circ Cardiovasc Qual Outcomes,2011
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献